Anne Armstrong
机构:University of Manchester, The Christie Hospital, The Christie NHS Foundation Trust · ORCID:0000-0002-0774-7006
发表论文 375 篇 · 总被引 13656 次 · h-index 42
代表论文
- Distant recurrence and margin involvement in invasive breast cancer (2026 · British Journal of Cancer · 被引 1)
- Table 1 from Durvalumab plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer (2026)
- Table 3 from Durvalumab plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer (2026)
- Table 4 from Durvalumab plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer (2026)
- Table 2 from Durvalumab plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer (2026)
- Supplementary Table S5 from Durvalumab plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer (2026)